Keitaro Hayashi

1.9k total citations
55 papers, 1.4k citations indexed

About

Keitaro Hayashi is a scholar working on Molecular Biology, Immunology and Biochemistry. According to data from OpenAlex, Keitaro Hayashi has authored 55 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Molecular Biology, 21 papers in Immunology and 15 papers in Biochemistry. Recurrent topics in Keitaro Hayashi's work include Amino Acid Enzymes and Metabolism (15 papers), Immune Cell Function and Interaction (13 papers) and T-cell and B-cell Immunology (10 papers). Keitaro Hayashi is often cited by papers focused on Amino Acid Enzymes and Metabolism (15 papers), Immune Cell Function and Interaction (13 papers) and T-cell and B-cell Immunology (10 papers). Keitaro Hayashi collaborates with scholars based in Japan, United States and Canada. Keitaro Hayashi's co-authors include Naohiko Anzai, Promsuk Jutabha, Hitoshi Endou, Amnon Altman, Masanobu Satake, Sonoko Habu, Hironori Sagara, Motoshi Ouchi, Toshio Watanabe and Natsumi Abe and has published in prestigious journals such as Journal of Biological Chemistry, The Journal of Experimental Medicine and Journal of Clinical Oncology.

In The Last Decade

Keitaro Hayashi

54 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Keitaro Hayashi Japan 20 669 496 252 249 183 55 1.4k
Keyvan Mahboubi United States 15 700 1.0× 331 0.7× 284 1.1× 140 0.6× 173 0.9× 22 1.3k
Maurizio Orlandini Italy 26 1.3k 1.9× 208 0.4× 493 2.0× 104 0.4× 217 1.2× 66 1.9k
Jay McQuillan United States 12 697 1.0× 385 0.8× 249 1.0× 50 0.2× 292 1.6× 15 1.4k
Toshimitsu Suhara Japan 18 855 1.3× 352 0.7× 179 0.7× 66 0.3× 189 1.0× 21 1.4k
Dony Maiguel United States 12 514 0.8× 156 0.3× 80 0.3× 110 0.4× 117 0.6× 16 981
R. J. A. Wanders Netherlands 23 1.7k 2.5× 276 0.6× 109 0.4× 236 0.9× 163 0.9× 55 2.0k
Jack Leslie United Kingdom 17 396 0.6× 174 0.4× 184 0.7× 106 0.4× 208 1.1× 34 1.1k
David Fernández United States 18 605 0.9× 898 1.8× 284 1.1× 37 0.1× 116 0.6× 29 1.8k
Xiaorong Gu United States 21 1.4k 2.1× 323 0.7× 113 0.4× 61 0.2× 118 0.6× 45 2.5k
Astrid Eder United States 14 1.3k 1.9× 308 0.6× 259 1.0× 121 0.5× 233 1.3× 17 1.6k

Countries citing papers authored by Keitaro Hayashi

Since Specialization
Citations

This map shows the geographic impact of Keitaro Hayashi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Keitaro Hayashi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Keitaro Hayashi more than expected).

Fields of papers citing papers by Keitaro Hayashi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Keitaro Hayashi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Keitaro Hayashi. The network helps show where Keitaro Hayashi may publish in the future.

Co-authorship network of co-authors of Keitaro Hayashi

This figure shows the co-authorship network connecting the top 25 collaborators of Keitaro Hayashi. A scholar is included among the top collaborators of Keitaro Hayashi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Keitaro Hayashi. Keitaro Hayashi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Hayashi, Keitaro & Osamu Kaminuma. (2022). Therapeutic Potential for Intractable Asthma by Targeting L-Type Amino Acid Transporter 1. Biomolecules. 12(4). 553–553. 2 indexed citations
2.
Miura, Kento, Mayumi Saeki, Norimasa Yamasaki, et al.. (2021). L-type amino acid transporter 1 inhibitor suppresses murine Th2 cell-mediated bronchial hyperresponsiveness independently of eosinophil accumulation. Asia Pacific Allergy. 11(3). e33–e33. 4 indexed citations
3.
Shimizu, Yasuo, Yusuke Nakamura, Yasuhiro Horibata, et al.. (2020). Imaging of lysophosphatidylcholine in an induced pluripotent stem cell-derived endothelial cell network. Regenerative Therapy. 14. 299–305. 6 indexed citations
4.
Satou, Motoyasu, Jason Wang, Tokiko Suzuki, et al.. (2020). L-type amino acid transporter 1, LAT1, in growth hormone-producing pituitary tumor cells. Molecular and Cellular Endocrinology. 515. 110868–110868. 15 indexed citations
5.
Hayashi, Keitaro, et al.. (2019). Fluvastatin is effective against thymic carcinoma. Life Sciences. 240. 117110–117110. 6 indexed citations
6.
Ouchi, Motoshi, Kenzo Oba, Kohei Kaku, et al.. (2017). Uric acid lowering in relation to HbA1c reductions with the SGLT2 inhibitor tofogliflozin. Diabetes Obesity and Metabolism. 20(4). 1061–1065. 22 indexed citations
7.
Otani, Naoyuki, Motoshi Ouchi, Keitaro Hayashi, et al.. (2016). Molecular Mechanism of the Urate-lowering Effects of Calcium Channel Blockers. 43(1). 23–29. 2 indexed citations
8.
Hayashi, Keitaro & Naohiko Anzai. (2014). Role of LAT1 in the Promotion of Amino Acid Incorporation in Activated T Cells. Critical Reviews in Immunology. 34(6). 467–479. 8 indexed citations
9.
Ikari, Akira, et al.. (2014). Downregulation of transient receptor potential M6 channels as a cause of hypermagnesiuric hypomagnesemia in obese type 2 diabetic rats. American Journal of Physiology-Renal Physiology. 308(12). F1386–F1397. 20 indexed citations
10.
Abe, Hideyuki, Takao Kamai, Keitaro Hayashi, et al.. (2014). The Rho-kinase inhibitor HA-1077 suppresses proliferation/migration and induces apoptosis of urothelial cancer cells. BMC Cancer. 14(1). 412–412. 34 indexed citations
11.
Anzai, Naohiko, Shin Wakui, Promsuk Jutabha, et al.. (2011). Human Drug Transporter Gene-expressing Cells are Useful Alternatives to Predict Pharmacokinetics in Man. 16(2). 66–73. 1 indexed citations
12.
Hundt, Matthias, Hiroki Tabata, Myung‐Shin Jeon, et al.. (2006). Impaired Activation and Localization of LAT in Anergic T Cells as a Consequence of a Selective Palmitoylation Defect. Immunity. 24(5). 513–522. 82 indexed citations
13.
Abe, Natsumi, Kazuyoshi Kohu, Keitaro Hayashi, et al.. (2005). Reduction of Runx1 Transcription Factor Activity Up-Regulates Fas and Bim Expression and Enhances the Apoptotic Sensitivity of Double Positive Thymocytes. The Journal of Immunology. 175(7). 4475–4482. 12 indexed citations
14.
Kohu, Kazuyoshi, Takehito Sato, Keitaro Hayashi, et al.. (2005). Overexpression of the Runx3 Transcription Factor Increases the Proportion of Mature Thymocytes of the CD8 Single-Positive Lineage. The Journal of Immunology. 174(5). 2627–2636. 67 indexed citations
15.
Hayashi, Keitaro, Waka Natsume, Toshio Watanabe, et al.. (2003). The Runx1 Transcription Factor Inhibits the Differentiation of Naive CD4 + T Cells into the Th2 Lineage by Repressing GATA3 Expression. The Journal of Experimental Medicine. 198(1). 51–61. 111 indexed citations
16.
Hayashi, Keitaro, Natsumi Abe, Toshio Watanabe, et al.. (2001). Overexpression of AML1 Transcription Factor Drives Thymocytes into the CD8 Single-Positive Lineage. The Journal of Immunology. 167(9). 4957–4965. 54 indexed citations
17.
Hayashi, Keitaro, Waka Natsume, Toshio Watanabe, et al.. (2000). Diminution of the AML1 Transcription Factor Function Causes Differential Effects on the Fates of CD4 and CD8 Single-Positive T Cells. The Journal of Immunology. 165(12). 6816–6824. 56 indexed citations
18.
Yamamoto, Kazuhiko, Kayo Masuko, S Takahashi, et al.. (1995). Accumulation of distinct T cell clonotypes in human solid tumors.. The Journal of Immunology. 154(4). 1804–1809. 39 indexed citations
19.
Hoshi, Kazuto, Akira Saitō, Mitsuaki Suzuki, Keitaro Hayashi, & Ryuzo Yanagimachi. (1982). [Effects of agents used for removal of zona pellucida on human sperm penetration into zona-free hamster egg].. PubMed. 34(12). 2229–34. 7 indexed citations
20.
Hayashi, Keitaro, et al.. (1960). OBSERVATIONS ON THE DUODENAL SPREAD OF GASTRIC CANCER. 6(2). 101–110. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Keyvan Mahboubi Breakdown of academic impact, for papers by Maurizio Orlandini Breakdown of academic impact, for papers by Jay McQuillan Breakdown of academic impact, for papers by Toshimitsu Suhara Breakdown of academic impact, for papers by Dony Maiguel Breakdown of academic impact, for papers by R. J. A. Wanders Breakdown of academic impact, for papers by Jack Leslie Breakdown of academic impact, for papers by David Fernández Breakdown of academic impact, for papers by Xiaorong Gu Breakdown of academic impact, for papers by Astrid Eder
Rankless by CCL
2026